H. Refsum

发表

The interaction between nitrous oxide and cobalamin

P. Ueland, A. B. Guttormsen, H. Refsum, 1994 .

Disruption of a Regulatory System Involving Cobalamin Distribution and Function in a Methionine-dependent Human Glioma Cell Line*

B. Seetharam, R. Banerjee, P. Ueland, 1998, The Journal of Biological Chemistry.

Preoperative Methionine Loading Enhances Restoration of the Cobalamin‐dependent Enzyme Methionine Synthase after Nitrous Oxide Anesthesia

P. Ueland, A. Svardal, A. Guttormsen, 1994, Anesthesiology.

Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: Methionine loading of non‐transformed, transformed, proliferating, and quiescent cells in culture

O. Vintermyr, P. Ueland, H. Refsum, 1991, Journal of cellular physiology.

Simulation of an electron source based calibrating system for an ionisation profile monitor

B. Dehning, J. Koopman, H. Refsum, 2005 .

Design, Simulation and Testing of a 2D Electron Source Based Calibrating System for a Proton Beam Ionisation Profile Monitor

B. Dehning, H. Refsum, 2004 .

Response of the methionine synthase system to short‐term culture with homocysteine and nitrous oxide and its relation to methionine dependence

P. Ueland, T. Fiskerstrand, H. Refsum, 1997, International journal of cancer.

Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis.

P. Ueland, Jicun Ren, H. Refsum, 1998, Clinical chemistry.

Total homocysteine in plasma or serum: methods and clinical applications.

P. Ueland, H. Refsum, M. Malinow, 1993, Clinical chemistry.

Homocysteine and other thiols in plasma and urine: automated determination and sample stability.

P. Ueland, T. Fiskerstrand, H. Refsum, 1993, Clinical chemistry.

Homocysteine and its disulfide derivatives: a suggested consensus terminology.

I. Rosenberg, H. Blom, D. Wilcken, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.

P. Ueland, T. Fiskerstrand, H. Refsum, 1994, The Journal of nutrition.

Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration.

P. Ueland, T. Fiskerstrand, A. Svardal, 1993, Clinical chemistry.

Cell kinetics of the rat corneal epithelium

E. Haaskjold, R. Bjerknes, S. Refsum, 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer.

M. Shipchandler, A. Andersson, E. Moore, 1995, Clinical chemistry.

A common methylenetetrahydrofolate reductase gene mutation and longevity.

P. Ueland, L. Brudin, L. Fransson, 1998, Atherosclerosis.

Determinants of cobalamin status in newborns.

Anne-Lise Bjørke Monsen, S. Vollset, P. Ueland, 2001, Pediatrics.

Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies.

S. Sandberg, P. Ueland, H. Refsum, 1999, Clinical chemistry.

Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.

P. Ueland, H. Refsum, F. Wesenberg, 1991, Cancer research.

Homocysteine and cardiovascular disease

S. Vollset, P. Ueland, S. Vollset, 1996 .

The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.

H. Blom, L. Kluijtmans, F. Kok, 1997, Atherosclerosis.

Homocysteine and cardiovascular disease.

S. Vollset, P. Ueland, S. Vollset, 1998, Annual review of medicine.

Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine.

P. Ueland, J. Lindemans, A. Guttormsen, 1992, Clinical pharmacology and therapeutics.

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

J. Witteman, A. Evans, G. Boers, 1997, JAMA.

Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations

L. Bouter, S. Vollset, G. Nijpels, 2005, European Journal of Clinical Nutrition.

Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system.

P. Ueland, A. Svardal, P. Aukrust, 1996, The Journal of nutrition.

Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.

P. Ueland, F. Wesenberg, H. Refsum, 1991, Cancer research.

Homocysteine in frozen plasma samples. A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis?

H. Refsum, B. Israelsson, L. Brattström, 1993, Scandinavian journal of clinical and laboratory investigation.

Kinetics of plasma homocysteine in healthy subjects after peroral homocysteine loading.

P. Ueland, T. Fiskerstrand, H. Refsum, 1993, Clinical chemistry.

Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype.

P. Ueland, A. Guttormsen, H. Refsum, 2001, American journal of medical genetics.

Assessment of homocysteine status

P. Ueland, T. Fiskerstrand, A. Guttormsen, 1997, Journal of Inherited Metabolic Disease.

Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency.

P. Ueland, A. Guttormsen, H. Refsum, 1996, The American journal of clinical nutrition.

Methotrexate sensitivity in Down's syndrome: a hypothesis

P. Ueland, H. Refsum, B. Christensen, 2004, Cancer Chemotherapy and Pharmacology.

Cystathionine β-Synthase Deficiency: Metabolic Aspects

P. Ueland, S. Mudd, H. Refsum, 1997 .

Coffee and homocysteine.

S. Vollset, P. Ueland, S. Vollset, 2000, The American journal of clinical nutrition.

Variability and determinants of total homocysteine concentrations in plasma in an elderly population.

C. Frost, R. Clarke, K. Khaw, 1998, Clinical chemistry.

Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia.

S. Tonstad, P. Ueland, H. Refsum, 1997, Circulation.

The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine.

S. Tonstad, P. Ueland, H. Refsum, 1998, The Journal of pediatrics.